Drugs by Condition

Restless Legs Syndrome Medications

Drugs associated with Restless Legs Syndrome

The following drugs and medications are in some way related to, or used in the treatment of Restless Legs Syndrome. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-conditions

Drug Name ( View by: Brand \| Generic )	Reviews	Ratings
Lyrica (Pro, More...) generic name: pregabalin class: gamma-aminobutyric acid analogs	0 review(s)	Rate It!	9.5
Klonopin (Pro, More...) generic name: clonazepam class: benzodiazepine anticonvulsants, benzodiazepines	6 review(s)	Rate It!	7.9
Neurontin (Pro, More...) generic name: gabapentin class: gamma-aminobutyric acid analogs	5 review(s)	Rate It!	8.7
Ultram (Pro, More...) generic name: tramadol class: miscellaneous analgesics	2 review(s)	Rate It!	7.3
Mirapex (More...) generic name: pramipexole class: dopaminergic antiparkinsonism agents	15 review(s)	Rate It!	9.1
Requip (More...) generic name: ropinirole class: dopaminergic antiparkinsonism agents	7 review(s)	Rate It!	8.1
Catapres (Pro, More...) generic name: clonidine class: antiadrenergic agents, centrally acting	0 review(s)	Not rated - Be the first
Ultram ER (More...) generic name: tramadol class: miscellaneous analgesics	1 review(s)	Rate It!	2.0
Klonopin Wafer (More...) generic name: clonazepam class: benzodiazepine anticonvulsants, benzodiazepines	1 review(s)	Rate It!	5.0
Gabarone (More...) generic name: gabapentin class: gamma-aminobutyric acid analogs	0 review(s)	Rate It!	4.0
Requip Starter Kit (More...) generic name: ropinirole class: dopaminergic antiparkinsonism agents	0 review(s)	Not rated - Be the first
Larodopa (More...) generic name: levodopa class: dopaminergic antiparkinsonism agents	0 review(s)	Not rated - Be the first

Restless Legs Syndrome Medications in the Pipeline

Solzira (gabapentin enacarbil)

March 16, 2009 - XenoPort to Receive $23 Million in Milestone Payments Associated With FDA Acceptance of Solzira NDA
January 9, 2009 - GSK and XenoPort Resubmit New Drug Application for Solzira in Restless Legs Syndrome
November 10, 2008 - GSK and XenoPort Announce Plans to Withdraw and Resubmit New Drug Application Requesting Approval of Solzira for Restless Legs Syndrome
September 16, 2008 - GSK and XenoPort Announce Submission of NDA Requesting FDA Approval of Solzira for Restless Legs Syndrome

Latest Restless Legs Syndrome Blog Post

Clinical Trials Update: June 8, 2009
-- Here are the latest clinical trials, courtesy of ClinicalConnectionc.om and CenterWatch: Restless Legs Syndrome An estimated 12 million Americans have restless legs syndrome (RLS), which is characterized by discomfort or pain in the legs that worsens...

View all Restless Legs Syndrome blog posts.

Restless Legs Syndrome Support Group Questions

Go to the Restless Legs Syndrome support group or view all Restless Legs Syndrome questions.

Ask a Question about Restless Legs Syndrome:

Browse drugs by condition:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

	Search:
Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	Advanced Search